Xiangqin Weng

机构：Shanghai Jiao Tong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Ruijin Hospital, Shanghai Institute of Hematology, First Affiliated Hospital Zhejiang University · ORCID：0000-0002-9504-3331

发表论文 69 篇 · 总被引 2533 次 · h-index 21

代表论文

• Concurrent remission of lymphoma and Sjögren’s disease following anti-CD19 chimeric antigen receptor-T cell therapy for diffuse large B-cell lymphoma: a case report (2023 · Frontiers in Immunology · 被引 48)
• The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients (2024 · Blood Cancer Journal · 被引 33)
• Aging and comprehensive molecular profiling in acute myeloid leukemia (2024 · Proceedings of the National Academy of Sciences · 被引 23)
• Refined risk stratification helps guiding transplantation choice in adult BCR::ABL1-positive acute lymphoblastic leukemia (2024 · Blood Cancer Journal · 被引 8)
• <i>ETV6::ACSL6</i> translocation-driven super-enhancer activation leads to eosinophilia in acute lymphoblastic leukemia through IL-3 overexpression (2024 · Haematologica · 被引 8)
• Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiationof Acute Myeloid Leukemia Cells by Inhibiting WNT/β-Catenin Pathway (2023 · Anti-Cancer Agents in Medicinal Chemistry · 被引 8)